Neurology Archives - Page 4 of 19 - REBEL EM

REBEL Core Cast – Basics of EM – Introduction

by Ellsworth Wright posted June 1, 2022 No Comments

REBEL Core Cast – Basics of Emergency Medicine Podcast Welcome to the EMRA Basics of Emergency Medicine Podcast. I am your host EJ Wright, and the following series is an all encompassing approach to the most common chief complaints in ...

Abdominal and GastroinstestinalAllergy and ImmunologyCardiovascularDermatologyEndocrine, Metabolic, Fluid, and ElectrolytesEnvironmentalHead, Eye, Ear, Nose, and ThroatHematology and OncologyInfectious DiseaseNeurologyObstetrics and GynecologyOrthopedicsRenal and GenitourinaryResuscitationThoracic and RespiratoryToxicologyTrauma

RESCUE-Japan LIMIT Trial

by Anand Swaminathan posted May 5, 2022 No Comments

Background: The publication of the MR CLEAN trial in January 2015 changed the face of ischemic stroke care. This was the first study demonstrating a benefit to endovascular treatment of a specific subset of ischemic stroke patients: those with a ...

Neurology

Effect of Intra-Arrest Transport and eCPR on Neurologic Outcomes in Refractory OHCA

by Mark Ramzy posted March 21, 2022 No Comments

Background Information: Refractory out of hospital cardiac arrest (OHCA) is defined as prolonged cardiac arrest and cardiac arrest without return of spontaneous circulation (ROSC). In addition to an already morbid condition, the chances of these patients surviving drops below 5% ...

CardiovascularNeurologyResuscitation

Andexanet Alfa Vs. Four-Factor PCC: Is Andexanet Alfa Worth The Hype?

by Sarah Aly, DO posted February 28, 2022 No Comments

Background: Oral factor Xa inhibitors (FXi) have been associated with major and fatal bleeding events, including intracranial hemorrhage (ICH). In randomized controlled trials, both rivaroxaban and apixaban are associated with ICH at rates that range from 0.1 to 4% (Agnelli ...

Hematology and OncologyNeurologyTrauma

MR CLEAN-NO IV: Endovascular Treatment for Stroke Compared to Alteplase Followed by Endovascular Treatment: No Difference, But Also Not Not Worse

by Thomas del Ninno, MD posted January 6, 2022 No Comments

Background: While the effects of stroke can be both debilitating and devastating, the benefit of certain treatments have not always been clear and the data supporting them are fraught with controversy. Reanalysis of the two trials demonstrating the benefit of thrombolytics ...

Neurology